The largest database of trusted experimental protocols

Pgl3 report luciferase vector

Manufactured by Thermo Fisher Scientific
Sourced in United States

The PGL3-REPORT luciferase vector is a plasmid used in molecular biology research. It contains the firefly luciferase gene as a reporter for gene expression studies.

Automatically generated - may contain errors

6 protocols using pgl3 report luciferase vector

1

Luciferase Assay for JAK2 3'UTR

Check if the same lab product or an alternative is used in the 5 most similar protocols
A fragment of the wild type (wt) JAK2 3′-UTR and a mutated (mt) JAK2 3′-UTR were cloned into the downstream region of the luciferase gene in the pGL3- REPORT luciferase vector (Invitrogen). For the luciferase assay, MGC-803 cells were co-transfected with pGL3-wt JAK2 3′-UTR or pGL3-mt JAK2 3′-UTR and precursor miR-216a or scrambled controls. Reporter activity was measured using a dual-luciferase reporter assay system (Promega, Madison, Wisconsin, USA). Firefly luciferase activity was normalized against Renilla luciferase activity.
+ Open protocol
+ Expand
2

Validating miR-145 Target MAPK1

Check if the same lab product or an alternative is used in the 5 most similar protocols
To identify the target, miR-145 was subjected to the online software TargetScan version 7.2 (http://www.targetscan.org). For the luciferase reporter assay, the binding sites of the wild-type (WT) and the mutated (MUT) MAPK1 3′-UTR were cloned into the downstream region of the luciferase gene in the PGL3-REPORT luciferase vector (Invitrogen; Thermo Fisher Scientific, Inc.). The cells were then subjected to co-transfection with the WT and MUT PGL3-MAPK1-3′ UTR vectors and the miR-145 mimics. Finally, the luciferase activity was determined using a Luciferase Reporter Assay kit (Promega Corporation, Madison, WI, USA) as per the manufacturer’s protocol, and Renilla luciferase activity was used to normalize the data.
+ Open protocol
+ Expand
3

miR-544 Binding Site Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Wild-type (wt) and mutated (mut) putative miR-544-binding sites in E2F5 3′-untranslated region (UTR) were cloned into the downstream region of the luciferase gene in the pGL3-REPORT luciferase vector (Invitrogen; Thermo Fisher Scientific, Inc.). For the reporter assay, the cells were co-transfected with wt or mut pGL3-E2F5-3′-UTR vectors and miR-544 mimics using Lipofectamine 2000 (Invitrogen; Thermo Fisher Scientific, Inc.). After 24 h, Luciferase activities were measured with a Dual Luciferase Reporter Assay kit (Promega Corporation), according to the manufacturer's protocol. Data were normalized against the activity of the Renilla luciferase activity.
+ Open protocol
+ Expand
4

Luciferase Assay to Validate miR-876-5p Targeting

Check if the same lab product or an alternative is used in the 5 most similar protocols
To identify the target, miR‐876‐5p was subjected to the online platform starBase V3.0.20 For the luciferase reporter assay, the binding sites of the wild‐type (wt) and the mutated (mt) c‐Met 3′‐UTR were cloned into the downstream region of the luciferase gene in the PGL3‐REPORT luciferase vector (Invitrogen). The HEK293T cells were then subjected to cotransfection with the wt or mt PGL3‐c‐Met‐3′UTR vectors and precursor miR‐876‐5p or miR‐876‐5p inhibitors. Finally, the luciferase activity was determined using a Luciferase Reporter Assay kit (Promega Corporation, Madison, WI) as per the manufacturer's protocol, and Renilla luciferase activity was used to normalize the data.
+ Open protocol
+ Expand
5

Luciferase Reporter Assay for miR-107 Targeting of ESR1 3'UTR

Check if the same lab product or an alternative is used in the 5 most similar protocols
A DNA fragment comprised ofa partial wild-type 3′UTR of ESR1 or a corresponding mutant 3′UTR of ESR1 was chemically synthesized and cloned into the pGL3-REPORT luciferase vector containing Renilla luciferase and firefly luciferase (Ambion; Thermo Fisher Scientific, Inc.) downstream of the luciferase gene (designated pGL3-ESR1-3′UTR-WT and pGL3-ESR1-3′UTR-MT, respectively). The nucleotide sequences of the plasmid constructs were confirmed by DNA sequencing. All steps of the luciferase reporter assay were performed in accordance with procedures previously described (16 (link),17 (link)). Briefly, 293 cells (5×104) were seeded into 24-well plates and transfected with 0.2 µg of either pGL3-ESR1-3′UTR-WT or pGL3-ESR1-3′UTR-MT, with or without 50 nM miR-107m or miR-107m NC using Lipofectamine 2000 transfection reagent according to the manufacturer's protocol. After 48 h, we used the dual luciferase reporter assay system to assess the luciferase activity (Promega Corp., Madison, WI, USA) and the results were expressed as the relative luciferase activity (firefly LUC/Renilla LUC). Meanwhile, ERα was the predicted target of miR-107 using the miR target prediction algorithm TargetScan (http://targetscan.org/), Pictar and miRanda.
+ Open protocol
+ Expand
6

Validating miR-32 Regulation of EZH2

Check if the same lab product or an alternative is used in the 5 most similar protocols
Potential targets of miR-32 were predicted by choosing the bioinformatics analysis software miRanda (www.microrna.org/microrna/home.do) and TargetScan (www.targetscan.org). The wild type (WT) and mutant type (Mut) 3′-UTR of EZH2 were cloned into pGL3-REPORT luciferase vector (Ambion; Thermo fisher Scientific, Inc., California). For the luciferase assay, the cells were seeded into a 24-well plate at a density of 1.5 × 105 cells/well and cultured overnight at 37°C prior to cotransfected with a reporter plasmid, along with miR-32 mimics and WT or Mut 3′-UTR of EZH2 using Lipofectamine 2000 transfection reagent at 37°C. Following 48 hours of incubation, the cells were harvested, and then detected by using Dual-Luciferase Reporter Assay System (Promega).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!